BB1 · ASX

Blinklab Limited (ASX:BB1)

AU$0.56

 0.01 (1.818%)
ASX:Live
19/09/2025 02:45:23 PM
HALO Ords GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

BB1 Overview

BB1 Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Weak

GARP

Very Weak

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

BB1 Price Chart

Key Stats

Market Cap

AU$23.80M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.21 - 0.59

Trade Value (12mth)

AU$23,976.00

1 week

0%

1 month

6.8%

YTD

92.98%

1 year

144.44%

All time high

0.59

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Technology

Next Company Report Date

28-Aug-26

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

BB1 Announcements

Latest Announcements

Date Announcements

18 September 25

The Vanderbilt Kennedy Center Onboarded

×

The Vanderbilt Kennedy Center Onboarded

17 September 25

The University of Missouri - Thompson Center - Engaged

×

The University of Missouri - Thompson Center - Engaged

11 September 25

Date of AGM & Closing Date for Director Nominations

×

Date of AGM & Closing Date for Director Nominations

28 August 25

Appendix 4G & Corporate Governance Statement

×

Appendix 4G & Corporate Governance Statement

28 August 25

2025 Annual Report & Appendix 4E

×

2025 Annual Report & Appendix 4E

26 August 25

Two Additional Strategic Partnerships Advance FDA Submission

×

Two Additional Strategic Partnerships Advance FDA Submission

21 August 25

University of Pennsylvania Perelman School of Med Onboarded

×

University of Pennsylvania Perelman School of Med Onboarded

19 August 25

Presentation - TechKnow Invest Roadshow Conference

×

Presentation - TechKnow Invest Roadshow Conference

13 August 25

Section 708A Notice

×

Section 708A Notice

13 August 25

Application for quotation of securities - BB1

×

Application for quotation of securities - BB1

25 July 25

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

11 July 25

Change of Director's Interest Notice x4

×

Change of Director's Interest Notice x4

09 July 25

Section 708A Notice

×

Section 708A Notice

09 July 25

Application for quotation of securities - BB1

×

Application for quotation of securities - BB1

09 July 25

Notification regarding unquoted securities - BB1

×

Notification regarding unquoted securities - BB1

09 July 25

Notification regarding unquoted securities - BB1

×

Notification regarding unquoted securities - BB1

08 July 25

UNMC Engaged as Second Site in Main Phase of FDA510(k) Study

×

UNMC Engaged as Second Site in Main Phase of FDA510(k) Study

02 July 25

Section 708A Notice

×

Section 708A Notice

02 July 25

Application for quotation of securities - BB1

×

Application for quotation of securities - BB1

30 June 25

Results of General Meeting

×

Results of General Meeting

30 June 25

Section 708A Notice

×

Section 708A Notice

30 June 25

Application for quotation of securities - BB1

×

Application for quotation of securities - BB1

30 June 25

US Ethics Approval Received for the Main Phase of FDA510(k)

×

US Ethics Approval Received for the Main Phase of FDA510(k)

24 June 25

Response to ASX Price and Volume Query

×

Response to ASX Price and Volume Query

20 June 25

Change in substantial holding

×

Change in substantial holding

20 June 25

Change in substantial holding

×

Change in substantial holding

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

BB1 Shortsell

Frequently Asked Questions

The current share price of Blinklab Limited (BB1:ASX) is AU$0.56.
The 52-week high share price for Blinklab Limited (BB1:ASX) is AU$0.59.
The 52-week low share price for Blinklab Limited (BB1:ASX)? is AU$0.21.
Blinklab Limited (BB1:ASX) does not pay a dividend.
Blinklab Limited (BB1:ASX) does not pay a dividend.
Blinklab Limited (BB1:ASX) has a franking level of 0.0%.
Blinklab Limited (BB1:ASX) is classified in the Technology.
The current share price of Blinklab Limited (BB1:ASX) is AU$0.56.
The 52-week high share price for Blinklab Limited (BB1:ASX) is AU$0.59.
The 52-week low share price for Blinklab Limited (BB1:ASX)? is AU$0.21.
Blinklab Limited (BB1:ASX) does not pay a dividend.
Blinklab Limited (BB1:ASX) does not pay a dividend.
Blinklab Limited (BB1:ASX) has a franking level of 0.0%.
Blinklab Limited (BB1:ASX) is classified in the Technology.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.